[ACRS] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
10-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 23.39%
YoY- 39.24%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 7,753 19,018 1,528 1,453 1,501 1,659 1,824 161.70%
PBT -27,635 -19,952 -20,532 -18,789 -22,804 -21,146 -18,161 32.19%
Tax 5,656 1,278 -3,862 -1,318 2,003 900 4,800 11.52%
NP -33,291 -21,230 -16,670 -17,471 -22,804 -21,146 -18,161 49.61%
Tax Rate - - - - - - - -
Total Cost 41,044 40,248 18,198 18,924 24,305 22,805 19,985 61.35%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -429.40 -111.63 -1,090.97 -1,202.41 -1,519.25 -1,274.62 -995.67 -42.83%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.50 -0.32 -0.25 -0.28 -0.37 -0.35 -0.34 29.22%
EPS Diluted -0.50 -0.32 -0.25 -0.28 -0.37 -0.35 -0.34 29.22%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.